Q1 FY27 results analysis · August 03, 2026

Park Medi World Ltd (PARKHOSPS) Q1 FY27 Results Analysis: PAT Jumps 42%, EBITDA Margin Contracts 115 bps

+35.2%PAT year on year, Rs. 88.59 Cr
Cofacto ResearchPublished August 03, 20262 min readPositive read
Quick summary

Park Medi World Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 475.71 Cr (+19.27% YoY) and PAT growth of +35.23% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 03, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 475.71 Cr (+19.27% YoY)
PAT (Q1)Rs. 88.59 Cr (+35.23% YoY)
EBITDA margin26.51% (+20 bps YoY)
EPS (Q1)Rs. 2.05 (+20.59% YoY)
Market capRs. 12,692.16 Cr
CMPRs. 294.60

Quarter Snapshot

Revenue grew 19.3% YoY with PAT to owners up 42.3% YoY, and PAT margin of 18.62% exceeded the guided range. However, EBITDA margin contracted 115 bps QoQ due to Panchkula ramp-up, and near-term margin pressure from new hospital additions is expected. The company remains on track for its FY27 margin guidance.

Key Investment Insights

Key Positives

  • Revenue grew 19.3% YoY to Rs.475.71 Cr, fifth consecutive quarter of double-digit growth.
  • PAT attributable to owners grew 42.3% YoY to Rs.82.51 Cr.
  • PAT margin of 18.62% exceeded the guided range of 15-17%.
  • Finance costs declined 35.2% YoY to Rs.9.81 Cr due to near-debt-free balance sheet.
  • Material costs as a percentage of revenue improved 133 bps YoY.
  • New bed capacity expanded from ~3,610 to ~3,960 with Panchkula commissioning.

Risk Factors

  • EBITDA margin contracted 115 bps QoQ to 26.51% due to Panchkula initial ramp-up drag.
  • New hospital ramp-up (Panchkula, upcoming Rudrapur, Zirakpur) expected to keep margins in lower half of guided band near term.
  • Other expenses as a percentage of revenue rose 39 bps YoY.
  • Effective tax rate dropped to 15.69% due to deferred tax benefit of Rs.9.34 Cr, which may not recur.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.